Obesity May Be Linked to Greater Threat of Stillbirth: FRIDAY PDE-5 inhibitor.


Obesity May Be Linked to Greater Threat of Stillbirth: – FRIDAY, Aug. 28, 2015 – – Obese pregnant women may have a almost twofold increased threat of stillbirth, a fresh study says. The leading known reasons for that higher risk look like high blood circulation pressure and placental disorders, the researchers suggested PDE-5 inhibitor . We’ve known for quite a while that obese women are more likely to have stillbirths, but that is one of the first and most comprehensive efforts to figure out why, study author Lisa Bodnar, an associate professor in the section of epidemiology at the University of Pittsburgh Graduate School of Public Health, stated in a university information release.

The FDA stressed that patients who take a DPP-4 inhibitor shouldn’t stop using the drug, but should contact their healthcare professional right away if indeed they experience severe and persistent joint pain. Doctors and other health-care workers should consider DPP-4 inhibitors just as one cause of severe joint discomfort and discontinue the medication if appropriate, the agency said. Type 2 diabetes, which is but not always associated with obesity often, affects about 95 % of individuals with diabetes. As the FDA noted, when untreated, type 2 diabetes can lead to serious problems, including blindness, nerve and kidney damage, and cardiovascular disease. .. FDA Warns of Joint Discomfort Tied to Common Type 2 Diabetes Drugs: – FRIDAY, Aug.